OncoCyte Corp (NAS:OCX)
$ 2.435 -0.095 (-3.75%) Market Cap: 40.99 Mil Enterprise Value: 43.22 Mil PE Ratio: 0 PB Ratio: 3.34 GF Score: 31/100

OncoCyte Corp DetermaIO™ Data KOL Webinar Transcript

Apr 19, 2021 / 03:30PM GMT
Release Date Price: $89 (-7.29%)
Operator

Good morning, and welcome to the OncoCyte KOL call on Novel Biomarkers in Identifying Appropriate Responders to Immune Checkpoint Inhibitors. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be available on the OncoCyte website following the conclusion of the event.

I'd now like to turn the call over to your host, Ronnie Andrews, President and CEO of OncoCyte. Please go ahead, Ronnie.

Ronald A. Andrews
OncoCyte Corporation - CEO, President & Director

Thank you, Tara. And good morning everyone, and thanks for taking time out of your day. We're very excited to bring to you another in our series of KOL events. Today, we have 2 amazing presenters, and we'll be happy to allow you guys to hear them. We want to give you a little introductory to the company for those that don't know us. So if we can change the slide, please?

Of course, there's going to be forward-looking statements today. I won't read this to you because I'll put everyone to sleep and there's way more important things to talk about.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot